[1]
|
牟学晶, 任欣欣, 赵海潞. 胰岛素治疗的系统风险[J]. 临床合理用药杂志, 2014(20): 12-14.
|
[2]
|
El, O. (1901) The Relation oe Diabetes Mellitus to Lesions of the Pancreas. Hyaline Degeneration of the Islands oe Langerhans. Journal of Experimental Medicine, 5, 527-540. https://doi.org/10.1084/jem.5.5.527
|
[3]
|
Höppener, J.W.M., Ahrén, B. and Lips, C.J.M. (2000) Islet Amyloid and Type 2 Diabetes Mellitus. New England Journal of Medicine, 343, 411-419. https://doi.org/10.1056/NEJM200008103430607
|
[4]
|
Westermark, P., Wernstedt, C., Wilander, E., et al. (1987) Amyloid Fi-brils in Human Insulinoma and Islets of Langerhans of the Diabetic Cat Are Derived from a Neuropeptide-Like Protein Also Present in Normal Islet Cells. Proceedings of National Academy of Sciences of USA, 84, 3881-3885. https://doi.org/10.1073/pnas.84.11.3881
|
[5]
|
Leighton, B. and Cooper, G.J. (1988) Pancreatic Amylin and Calcitonin Gene-Related Peptide Cause Resistance to Insulin in Skeletal Muscle in Vitro. Nature, 335, 632-635. https://doi.org/10.1038/335632a0
|
[6]
|
Hull, R.L., Westermark, G.T., Westermark, P., et al. (2004) Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes. Journal of Clinical Endocrinology & Metabolism, 89, 3629. https://doi.org/10.1210/jc.2004-0405
|
[7]
|
Johnson, K.H., O’Brien, T.D., Betsholtz, C., et al. (1989) Islet Amyloid, Is-let-Amyloid Polypeptide, and Diabetes Mellitus. New England Journal of Medicine, 321, 513-518. https://doi.org/10.1056/NEJM198908243210806
|
[8]
|
Johnson, K.H., O’Brien, T.D., Betsholtz, C., et al. (1992) Islet Amyloid Polypeptide: Mechanisms of Amyloidogenesis in the Pancreatic Islets and Potential Roles in Diabetes Mellitus. Laboratory Investi-gation: A Journal of Technical Methods and Pathology, 66, 522-535.
|
[9]
|
Booth, D.R., Sunde, M., Bellotti, V., et al. (1997) Insta-bility, Unfolding and Aggregation of Human Lysozyme Variants Underlying Amyloid Fibrillogenesis. Nature, 385, 787-793. https://doi.org/10.1038/385787a0
|
[10]
|
Westermark, P., Andersson, A. and Westermark, G.T. (2011) Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus. Physiological Reviews, 91, 795. https://doi.org/10.1152/physrev.00042.2009
|
[11]
|
Wimalawansa, S.J. (1996) Calcitonin Gene-Related Peptide and Its Receptors: Molecular Genetics, Physiology, Pathophysiology, and Therapeutic Potentials. Endocrine Reviews, 17, 533-585. https://doi.org/10.1210/edrv-17-5-533
|
[12]
|
Zhang, X.X., Pan, Y.H., Huang, Y.M., et al. (2016) Neuroendocrine Hormone Amylin in Diabetes. World Journal of Diabetes, 7, 189-197. https://doi.org/10.4239/wjd.v7.i9.189
|
[13]
|
Marzban, L., Tri-go-Gonzalez, G., Zhu, X., et al. (2004) Role of Beta-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Poly-peptide. Diabetes, 53, 141-148. https://doi.org/10.2337/diabetes.53.1.141
|
[14]
|
Zhao, H.L., Lai, F.M., Tong, P.C., et al. (2003) Prevalence and Clinicopathological Characteristics of Islet Amyloid in Chinese Patients with Type 2 Diabetes. Diabetes, 52, 2759-2766. https://doi.org/10.2337/diabetes.52.11.2759
|
[15]
|
Qiao, Y.C., Shen, J., Hong, X.Z., et al. (2016) Changes of Regu-latory T Cells, Transforming Growth Factor-Beta and Interleukin-10 in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Clinical Immunology, 170, 61-69. https://doi.org/10.1016/j.clim.2016.08.004
|
[16]
|
Westermark, G.T., Gebre-Medhin, S. and Westermark, D.F.S. (2000) Islet Amyloid Development in a Mouse Strain Lacking Endogenous Islet Amyloid Polypeptide (IAPP) But Expressing Human IAPP. Molecular Medicine, 6, 998-1007. https://doi.org/10.1007/BF03402051
|
[17]
|
Johnson, K.H., O’Brien, T.D., Hayden, D.W., et al. (1988) Immunolocalization of Islet Amyloid Polypeptide (IAPP) in Pancreatic Beta Cells by Means of Peroxidase-Antiperoxidase (PAP) and Protein A-Gold Tech-niques. American Journal of Pathology, 130, 1-8.
|
[18]
|
Schmitz, O., Brock, B. and Rungby, J. (2004) Amylin Agonists: A Novel Approach in the Treatment of Diabetes. Diabetes, 53, S233.
|
[19]
|
Cornish, J., Callon, K.E., Cooper, G.J., et al. (1995) Amylin Sti-mulates Osteoblast Proliferation and Increases Mineralized Bone Volume in Adult Mice. Biochemical and Biophysical Research Communications, 207, 133-139.
https://doi.org/10.1006/bbrc.1995.1163
|
[20]
|
Wimalawansa, S.J. (1997) Amylin, Calcitonin Gene-Related Peptide, Calcitonin, and Adrenomedullin: A Peptide Superfamily. Critical Reviews in Neurobiology, 11, 167-239. https://doi.org/10.1615/CritRevNeurobiol.v11.i2-3.40
|
[21]
|
Cornish, J., Callon, K.E., Gasser, J.A., et al. (2000) Systemic Ad-ministration of a Novel Octapeptide, Amylin-(1-8), Increases Bone Volume in Male Mice. American Journal of Physiology Endo-crinology and Metabolism, 279, E730-E735. https://doi.org/10.1152/ajpendo.2000.279.4.E730
|
[22]
|
Horcajada-Molteni, M.N., Davicco, M.J., Lebecque, P., et al. (2000) Amylin Inhibits Ovariectomy-Induced Bone Loss in Rats. The Journal of Endocrinology, 165, 663-668. https://doi.org/10.1677/joe.0.1650663
|
[23]
|
Bronsky, J. and Prusa, R. (2004) Amylin Fasting Plasma Levels Are Decreased in Patients with Osteoporosis. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 15, 243-247.
https://doi.org/10.1007/s00198-003-1538-5
|
[24]
|
Bronsky, J., Prusa, R. and Nevoral, J. (2006) The Role of Amylin and Related Peptides in Osteoporosis. International Journal of Clinical Chemistry, 373, 9-16.
|
[25]
|
Zhao, H.L., Tong, P.C., Lai, F.M., et al. (2004) Association of Glomerulopathy with the 5’-End Polymorphism of the Aldose Reductase Gene and Renal Insufficiency in Type 2 Diabetic Patients. Diabetes, 53, 2984.
https://doi.org/10.2337/diabetes.53.11.2984
|
[26]
|
Höppener, J.W., Ahrén, B. and Lips, C.J. (2000) Islet Amyloid and Type 2 Diabetes Mellitus. The New England Journal of Medicine, 343, 411-419. https://doi.org/10.1056/NEJM200008103430607
|
[27]
|
Cooper, G.J.S., Aitken, J.F. and Zhang, S. (2010) Is Type 2 Diabetes an Amyloidosis and Does It Really Matter (to Patients)? Diabetologia, 53, 1011-1016. https://doi.org/10.1007/s00125-010-1715-y
|
[28]
|
Hay, D.L., Chen, S., Lutz, T.A., et al. (2015) Amylin: Pharmacology, Physi-ology, and Clinical Potential. Pharmacological Reviews, 67, 564-600. https://doi.org/10.1124/pr.115.010629
|
[29]
|
Zhao, H.L., Sui, Y., Guan, J., et al. (2008) Higher Islet Amyloid Load in Men than in Women with Type 2 Diabetes Mellitus. Pancreas, 37, e68-e73. https://doi.org/10.1097/MPA.0b013e3181788e18
|
[30]
|
Zhao, H., Guan, J., Lee, H.M., et al. (2010) Up-Regulated Pan-creatic Tissue microRNA-375 Associates with Human Type 2 Diabetes through Beta-Cell Deficit and Islet Amyloid Deposition. Pancreas, 39, 843-846.
https://doi.org/10.1097/MPA.0b013e3181d12613
|
[31]
|
Zheng, T., Qin, L., Chen, B., et al. (2016) Association of Plasma DPP4 Activity with Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes: Results from the GDMD Study in China. Di-abetes Care, 39, 1594-1601.
https://doi.org/10.2337/dc16-0316
|
[32]
|
Qiao, Y.C., Ling, W., Pan, Y.H., et al. (2017) Efficacy and Safety of Pramlintide Injec-tion Adjunct to Insulin Therapy in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Oncotarget, 8, 66504-66515.
https://doi.org/10.18632/oncotarget.16008
|
[33]
|
Wr, F. (1982) The Discovery of Insulin. McClelland and Stewart, Toron-to.
|
[34]
|
Kurtzhals, P., Schäffer, L., Sørensen, A., et al. (2000) Correlations of Receptor Binding and Metabolic and Mitogenic Po-tencies of Insulin Analogs Designed for Clinical Use. Diabetes, 49, 999-1005.
https://doi.org/10.2337/diabetes.49.6.999
|